PFG Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Buy
10,863
+1,219
+13% +$1.25M 0.5% 33
2026
Q1
$8.87M Buy
9,644
+1,028
+12% +$1.04M 0.41% 44
2025
Q4
$9.26M Sell
8,616
-1,000
-10% -$956K 0.44% 40
2025
Q3
$7.34M Buy
9,616
+491
+5% +$365K 0.38% 49
2025
Q2
$7.11M Buy
9,125
+69
+0.8% +$53.6K 0.42% 46
2025
Q1
$7.48M Buy
9,056
+222
+3% +$185K 0.48% 37
2024
Q4
$6.82M Buy
8,834
+1,262
+17% +$1.04M 0.42% 37
2024
Q3
$6.71M Buy
7,572
+723
+11% +$650K 0.43% 38
2024
Q2
$6.2M Sell
6,849
-5,114
-43% -$4.09M 0.44% 39
2024
Q1
$9.31M Buy
11,963
+9,615
+409% +$6.84M 0.56% 29
2023
Q4
$1.37M Sell
2,348
-90
-4% -$52.5K 0.25% 87
2023
Q3
$1.31M Sell
2,438
-19
-0.8% -$9.79K 0.25% 81
2023
Q2
$1.15M Buy
2,457
+155
+7% +$65K 0.2% 106
2023
Q1
$791K Buy
+2,302
New +$776K 0.16% 138

Other funds holding LLY

PFG Investments's LLY Position: Q2 2026 in Review

PFG Investments increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $1.25M and bringing the position to 10,863 shares worth $13M. The position accounts for 0.5% of the portfolio, ranked #33.

PFG Investments first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 1,613 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PFG Investments held 10,863 shares of Eli Lilly worth $13M as of Q2 2026.
  • PFG Investments bought 1,219 Eli Lilly shares in Q2 2026, an estimated $1.25M.
  • Eli Lilly made up 0.5% of PFG Investments's portfolio in Q2 2026, its #33 holding.
  • PFG Investments first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 1,613 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.